These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18271811)

  • 1. Matrix metalloproteinase-9 expression in desmoplastic melanoma.
    Hoashi T; Kikuchi K; Watanabe S; Nanko H; Tamaki K
    J Dermatol; 2008 Feb; 35(2):122-3. PubMed ID: 18271811
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma.
    Yoshino Y; Kageshita T; Nakajima M; Funakubo M; Ihn H
    J Dermatol; 2008 Apr; 35(4):206-14. PubMed ID: 18419677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating matrix metalloproteinase-9 levels as a biomarker of disease.
    Gerlach RF; Tanus-Santos JE
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8887; author reply 8887-8. PubMed ID: 16361580
    [No Abstract]   [Full Text] [Related]  

  • 4. Melanoma progression in a changing environment.
    van Kempen LC; van Muijen GN; Ruiter DJ
    Eur J Cell Biol; 2007 Feb; 86(2):65-7. PubMed ID: 17241688
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro expression of gelatinases in reconstructed melanoma model composited MV3 cells.
    Lü Y; Zhang W; Lu HG
    Chin Med J (Engl); 2013 Aug; 126(16):3196-7. PubMed ID: 23981643
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of matrix metalloproteinases in serum of patients with melanoma: snarled in technical pitfalls.
    Zucker S; Cao J
    Clin Cancer Res; 2005 Jul; 11(14):5069-70. PubMed ID: 16033818
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
    Vihinen P; Koskivuo I; Syrjänen K; Tervahartiala T; Sorsa T; Pyrhönen S
    Melanoma Res; 2008 Aug; 18(4):268-73. PubMed ID: 18626311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of LDH isoenzyme determination in monitoring the clinical course of malignant melanoma in the human].
    Beyer C; Fiedler H; Wohlrab W; Zaumseil RP; Wittenbecher AE
    Dermatol Monatsschr; 1984; 170(6):391-4. PubMed ID: 6468709
    [No Abstract]   [Full Text] [Related]  

  • 9. De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation.
    Liu JW; Sun P; Yan Q; Paller AS; Gerami P; Ho N; Vashi N; Le Poole IC; Wang XQ
    Cancer Res; 2009 Nov; 69(22):8662-9. PubMed ID: 19903858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of nuclear Dicer correlates with melanoma progression.
    Jafarnejad SM; Sjoestroem C; Ardekani GS; Martinka M; Li G
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):147-9. PubMed ID: 23078192
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-glycuronidase activity in pigmented tumours of the human skin. Histochemical and biochemical study].
    Hewitt J; Guigon M; Bolubasz J; Masson C
    Rev Eur Etud Clin Biol; 1970 Apr; 15(4):416-23. PubMed ID: 5421867
    [No Abstract]   [Full Text] [Related]  

  • 12. Human cutaneous melanoma expresses a significant phosphate-dependent glutaminase activity: a comparison with the surrounding skin of the same patient.
    Zacharias DP; Lima MM; Souza AL; de Abranches Oliveira Santos ID; Enokiara M; Michalany N; Curi R
    Cell Biochem Funct; 2003 Mar; 21(1):81-4. PubMed ID: 12579526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis.
    Djafarzadeh R; Milani V; Rieth N; von Luettichau I; Skrablin PS; Hofstetter M; Noessner E; Nelson PJ
    Cancer Immunol Immunother; 2009 Mar; 58(3):361-71. PubMed ID: 18618109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Desmoplastic malignant melanoma].
    Gartman H
    Hautarzt; 1982 Jul; 33(7):401. PubMed ID: 7107285
    [No Abstract]   [Full Text] [Related]  

  • 15. Placental alkaline phosphatase positivity in metastatic melanoma.
    Frieling GW; Al-Zaid T; Prieto VG
    Am J Dermatopathol; 2014 Feb; 36(2):189-90. PubMed ID: 24561965
    [No Abstract]   [Full Text] [Related]  

  • 16. Wnt5a and PKC, a deadly partnership involved in melanoma invasion.
    Medrano EE
    Pigment Cell Res; 2007 Aug; 20(4):258-9. PubMed ID: 17630957
    [No Abstract]   [Full Text] [Related]  

  • 17. [Desmoplastic Spitz nevus: a histopathological review and comparison with desmoplastic melanoma].
    Nojavan H; Cribier B; Mehregan DR
    Ann Dermatol Venereol; 2009 Oct; 136(10):689-95. PubMed ID: 19801251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic melanoma: a heterogeneous entity in which subclassification as "pure" or "mixed" may have important prognostic significance.
    Scolyer RA; Thompson JF
    Ann Surg Oncol; 2005 Mar; 12(3):197-9. PubMed ID: 15827808
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: association to tumor derived alpha-N-acetylgalactosaminidase activity.
    Greco M; Mitri MD; Chiriacò F; Leo G; Brienza E; Maffia M
    Cancer Lett; 2009 Oct; 283(2):222-9. PubMed ID: 19394758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF kinase in melanoma development and progression.
    DeLuca AM; Srinivas A; Alani RM
    Expert Rev Mol Med; 2008 Feb; 10():e6. PubMed ID: 18279546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.